FDA daily

FDA daily for Friday, June 5, 2026

In this issue: 1 shortage update, 12 approvals, 25 device recalls, 31 device decisions and 140 label changes. 4 items touch categories MedGrid carries, and they come first.

For MedGrid's categories

Items in this issue that name a product category sold on MedGrid. Each links to its full FDA record; the chip opens that category's federal and state rules.

Drug shortages

FDA date:

FDA updated 1 shortage entry on Thu, Jun 4: 1 new, 1 to be discontinued.

Browse drug shortages in FDA data →

Drug and biologic approvals

FDA date:

On Fri, May 29 FDA approved 6 new applications (4 brand or biologic, 2 generic) and 6 supplements to existing ones.

  • CYPSEDO

    HAISCO · CIPEPOFOL

    NDA220482Drug (NDA)Prescription
  • EPINEPHRINE

    HIKMA · EPINEPHRINE

    ANDA220562Generic (ANDA)Prescription
  • ZAYNICH

    WOCKHARDT BIO AG · CEFEPIME HYDROCHLORIDE, ZIDEBACTAM

    NDA220787Drug (NDA)Prescription
  • OXCARBAZEPINE

    MSN · OXCARBAZEPINE

    ANDA209020Generic (ANDA)Prescription
  • CAVHANZA

    CYCLE · NILOTINIB

    NDA217379Drug (NDA)Prescription
  • XOCOVA

    SHIONOGI · ENSITRELVIR

    NDA220442Drug (NDA)Prescription
Browse drug and biologic approvals in FDA data →

Device recalls

FDA date:

FDA posted 25 device recalls from 5 firms on Fri, May 29.

Browse device recalls in FDA data →

Device clearances and approvals

FDA date:

FDA decided 22 510(k)s and 9 PMA decisions on Fri, May 22.

Browse device clearances and approvals in FDA data →

Label updates

FDA date:

140 drug labels took effect on Fri, May 22. Below: those, and labels carrying a boxed warning.

Browse label updates in FDA data →

How the FDA daily is written

Every issue is written from FDA's public data (openFDA) and nothing else: the counts, names, firms and reasons are FDA's own. openFDA posts each kind of record on its own delay, so each section covers one FDA date and says which. Shortages cover yesterday; approvals, drug and device recalls, and food and supplement recalls cover a week ago; device clearances and label changes cover two weeks ago. Every FDA date appears in exactly one issue. Complete response letters appear the day after FDA publishes a batch.

Subscribe with any feed reader, or point an email tool at the RSS feed to send each issue as a newsletter. Search any drug, device or company across every FDA dataset in the FDA data explorer.

Read FDA's day. Stock your practice.

Join free with your NPI: wholesale pricing from verified vendors, with the FDA and state rules for each category one click away.

Data from openFDA, FDA's public API. FDA says not to rely on it to make decisions about medical care and to treat every result as unvalidated; confirm against FDA's own record and the product labeling. Not medical or legal advice.